The Crosstalk of Hedgehog, PI3K and Wnt Pathways in Diabetes
Overview
Biophysics
Affiliations
Hyperglycaemia causes pancreatic β-cells to release insulin that then attaches to a specific expression of receptor isoform and reverses high glucose concentrations. It is well known that insulin is capable of initiating insulin-receptor substrate (IRS)/phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling pathways in target cells; such as liver, adipose tissues, and muscles. However, recent discoveries indicate that many other pathways, such as the Hedgehog (Hh) and growth factor-stimulating Wingless-related integration (Wnt) signaling pathways; are activated in hyperglycaemia as well. Although these two pathways are traditionally thought to have a decisive role in cellular growth and differentiation only, recent reports show that they are involved in regulating cellular homeostasis and energy balance. While insulin-activated IRS/PI3K/PKB pathway cascades are primarily known to reduce glucose production, it was recently discovered to increase the Hh signaling pathway's stability, thereby activating the PI3K/PKB/mammalian target of rapamycin complex 2 (mTORC2) signaling pathway. The Hh signaling pathway not only plays a role in lipid metabolism, insulin sensitivity, inflammatory response, diabetes-related complications, but crosstalks with the Wnt signaling pathway resulting in improved insulin sensitivity and decrease inflammatory response in diabetes.
The Pathological Mechanisms and Therapeutic Molecular Targets in Arteriovenous Fistula Dysfunction.
Yan R, Song A, Zhang C Int J Mol Sci. 2024; 25(17).
PMID: 39273465 PMC: 11395150. DOI: 10.3390/ijms25179519.
Jiang X, Li Y, Cao Z, Xu Q, Zhang J, Cao D Foods. 2024; 13(17).
PMID: 39272556 PMC: 11395265. DOI: 10.3390/foods13172791.
Li Y, Xu M, Chen J, Huang J, Cao J, Chen H Stem Cell Res Ther. 2024; 15(1):188.
PMID: 38937834 PMC: 11210168. DOI: 10.1186/s13287-024-03780-7.
AMPK pathway: an emerging target to control diabetes mellitus and its related complications.
Kakoti B, Alom S, Deka K, Halder R J Diabetes Metab Disord. 2024; 23(1):441-459.
PMID: 38932895 PMC: 11196491. DOI: 10.1007/s40200-024-01420-8.
Effect of Hypoglycemia and Rebound Hyperglycemia on Proteomic Cardiovascular Risk Biomarkers.
Nandakumar M, Sathyapalan T, Atkin S, Butler A Biomedicines. 2024; 12(6).
PMID: 38927344 PMC: 11201283. DOI: 10.3390/biomedicines12061137.